Printer Friendly
The Free Library
19,604,532 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Ashni Naturaceuticals Signs Exclusive Contract With AstaCarotene for the Distribution of Their AstaCaRx, Natural Astaxanthin Human Nutritional Supplements.


Health/Medical Writers

SALT LAKE CITY--(BW HealthWire)--Jan. 6, 2000

Ashni Naturaceuticals Inc. has entered into an exclusive agreement with AstaCarotene AB (Gustavsberg, Sweden) to act as sole U.S. distributor for AstaCaRx(TM), a natural astaxanthin human nutritional supplement.

AstaCaRx(TM) is a potent antioxidant antioxidant, substance that prevents or slows the breakdown of another substance by oxygen. Synthetic and natural antioxidants are used to slow the deterioration of gasoline and rubber, and such antioxidants as vitamin C (ascorbic acid), butylated hydroxytoluene  made from the red micro-algae Haematococcus pluvialis. With up to 550 times the antioxidant activity of vitamin E vitamin E
 or tocopherol

Fat-soluble organic compound found principally in certain plant oils and leaves of green vegetables. Vitamin E acts as an antioxidant in body tissues and may prolong life by slowing oxidative destruction of membranes.
 and 10 times the antioxidant activity of beta-carotene, AstaCaRx(TM) could potentially capture a significant share of the over $800 million in annual North American North American

named after North America.


North American blastomycosis
see North American blastomycosis.

North American cattle tick
see boophilusannulatus.
 antioxidant sales.

"Ashni is pleased to have the opportunity to develop this relationship with AstaCarotene. AstaCarotene produces and harvests high quality astaxanthin suitable for human consumption in sufficient quantities to accommodate a national marketing effort.

"Through controlled growth they've increased their production capacities significantly without compromising Good Manufacturing Practices (GMP GMP (guanosine monophosphate): see guanine. ) or having to deal with the serious contaminations that appear to plague some competitors," said Dinesh C. Patel, Ph.D., Ashni chairman, president and chief executive officer.

Since 1995, AstaCarotene has been producing and selling astaxanthin supplements for human consumption primarily in Scandinavia and select European countries.

International patents have been granted to AstaCarotene for the use of astaxanthin for improving muscle strength endurance and for treating muscle dysfunction; for the treatment/prevention of Helicobacter pylori Helicobacter pylori
A gramnegative rod-shaped bacterium that lives in the tissues of the stomach and causes inflammation of the stomach lining.

Mentioned in: Indigestion, Ulcers

Helicobacter pylori
 infections (ulcers); for increasing fertility; and as a dietary supplement Noun 1. dietary supplement - something added to complete a diet or to make up for a dietary deficiency
diet - a prescribed selection of foods

vitamin pill - a pill containing one or more vitamins; taken as a dietary supplement
. Patents are pending for a variety of other nutritional support nutritional support,
n the supply of foods and liquids necessary to advance healing and support health.
 products.

AstaCarotene has made a significant investment in clinical trials to study the beneficial effects of astaxanthin in humans. Clinical studies in humans have shown improved strength endurance and reduced gastric pain (heartburn heartburn, burning sensation beneath the breastbone, also called pyrosis. Heartburn does not indicate heart malfunction but results from nervous tension or overindulgence in food or drink. ) in dyspepsia dyspepsia: see indigestion.  patients.

"Ashni anticipates significant interest in AstaCaRx(TM) from several market segments," stated Jill Turner, Ashni vice president of business development. "With Ashni's strong industry relationships in the pharmaceutical, nutritional/supplement retail segments we expect to encounter a healthy degree of interest for this product.

"Ashni and AstaCarotene will also develop new patent-protected product combinations."

"Our experience gained during half a decade of marketing and sales activities in the human dietary supplement markets in combination with the extensive pioneering research into the effects of AstaCaRx(TM) on human health and physical performance give us the platform needed for entering the U.S. market with great confidence," said Johan Inborr, Ph.D., president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of AstaCarotene AB.

"In addition, Ashni Naturaceuticals Inc. provides exciting possibilities for systematic market penetration and further product development."

AstaCarotene is a research-based biotech company specializing in the production and development of natural astaxanthin for use in human and animal health care and disease prevention. Production facilities and corporate offices are located in Gustavsberg, Sweden, the research lab in Uppsala, Sweden.

Ashni Naturaceuticals Inc., with its corporate offices in Salt Lake City, specializes in the research, development and marketing of clinically tested and patent-protected naturaceutical products.
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 6, 2000
Words:471
Previous Article:`BBB' Rtg On $130M Trinity Mother Frances Bonds Affirmed.
Next Article:Jasco Expands GE Brand Surge Protection Line.



Related Articles
Cyanotech Reports Increased Demand for Its Products.
Cyanotech Expects Minimal Impact From U.S. District Court Denial of Motion for Summary Judgment.
Cyanotech Announces Direct Sales of BioAstin -- New Natural Astaxanthin Human Dietary Supplement; ``Woman's World'' Magazine Features Health Benefits...
Ashni Naturaceuticals Acquires BioNexus Genomics, Developer of Patent-pending Genomic/Proteomic/Signal Transduction Technology.
Cyanotech Initiates Clinical Trial of BioAstin for Relief of Carpal Tunnel Syndrome.
Igene Renews Manufacturing Contract; Appoints Exclusive Sales Agent.
Silico Insights and Ashni Naturaceuticals Collaborate in Proteomics Research to Build Novel Drug Targets.
Igene Purchases Their Exclusive Sales Agent ProBio.
FIRM LOOKS TO ASIAN MARKET : WHITEWING MAKES PHILIPPINE DEAL.
Cyanotech CEO Reports on Business Development Trip to Asia.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles